Novel targeted therapies for Parkinson's disease
Abstract Parkinson's disease (PD) is the second more common neurodegenerative disease with increasing incidence worldwide associated to the population ageing. Despite increasing awareness and significant research advancements, treatment options comprise dopamine repleting, symptomatic therapies...
Saved in:
Main Authors: | Theodora Ntetsika (Author), Paraskevi-Evita Papathoma (Author), Ioanna Markaki (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in circRNA-Targeted Therapy in Experimental Parkinson's Disease
by: Simoneide Souza Titze-, et al.
Published: (2023) -
Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
Published: (2019) -
Cell Therapy for Parkinson's Disease
by: Surabhi Shastry, et al.
Published: (2023) -
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
by: Kai Zhang, et al.
Published: (2021) -
Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease Kinases, GTPases and ATPases
by: Veerle Baekelandt
Published: (2015)